Creative Planning
CASM

Creative Planning’s CAS Medical Systems, Inc. CASM Stock Holding History

Creative Planning’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,800
Closed -$2K – 3549
2015
Q1 		$2K Buy
+1,800
New +$2.59K ﹤0.01% 3947

Other funds holding CASM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Creative Planning's CASM Position: Q2 2015 in Review

Creative Planning sold out of CAS Medical Systems, Inc. (CASM) in Q2 2015, closing a stake of 1,800 shares — an estimated $2K sold.

Creative Planning first reported a position in CASM in Q1 2015 and held it in 1 quarter. The position peaked at $2K in Q1 2015. 25 funds tracked by Wall St. Rank hold CASM as of Q2 2015.

  • Creative Planning reported no remaining CAS Medical Systems, Inc. position as of Q2 2015 after selling out during the quarter.
  • Creative Planning sold 1,800 CAS Medical Systems, Inc. shares in Q2 2015, an estimated $2K.
  • Creative Planning first reported a position in CAS Medical Systems, Inc. in Q1 2015 and held it in 1 quarter.
  • Creative Planning's CAS Medical Systems, Inc. position peaked at $2K in Q1 2015.
  • 25 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2015.

Based on Creative Planning's 13F filing for Q2 2015, filed 9 Jul 2015.